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ABSTRACT OF DISSERTATION 
 
 
 
 
 
SUPERNATANT PROTEIN FACTOR: INSIGHTS INTO ITS REGULATION 
AND ABILITY TO STIMULATE CHOLESTEROL SYNTHESIS IN VITRO AND IN 
CELL CULTURE 
 
 Supernatant protein factor (SPF) is a 46-kDa cytosolic protein that stimulates 
squalene monooxygenase, which catalyses the second committed step in cholesterol 
biosynthesis.  The mechanism by which SPF stimulates this enzyme is not understood 
and the goal of these studies was to see if SPF affected cholesterol synthesis in 
cultured cells.  Rat supernatant protein factor-like protein (SPF2) shares 77% sequence 
identity with human SPF.  In my studies SPF2 also stimulated squalene 
monooxygenase in vitro and incubation of SPF2 with protein kinase A (PKA) and Cδ 
increased its activity by about 2-fold, as shown earlier with SPF.  GTP and GDP 
prevented the stimulation of squalene monooxygenase by SPF2, suggesting that 
binding of these nucleotides inhibits SPF2. This inhibition could be prevented by the 
addition of α-tocopherol, although α-tocopherol alone had no effect on SPF2 activity in 
vitro.  Expression of human SPF in hepatoma cells, which lack expression of 
endogenous SPF, increased cholesterol synthesis by 2-fold and addition of dibuytryl-
cAMP, a PKA activator, to these cells yielded an additional 62% increase whereas 
addition of a PKA inhibitor completely blocked the ability of SPF to stimulate cholesterol 
synthesis.  To further confirm a role for phosphorylation in the regulation of SPF, 
substitution of alanine for serine-289 (a putative PKA recognition site) reduced the 
PKA-mediated activation of SPF in vitro by 50%, as measured with microsomal 
squalene monooxygenase and completely blocked the ability of SPF to stimulate 
cholesterol synthesis in hepatoma cells.  In further structure-function studies, 
deletion of the carboxy-terminal Golgi-dynamics domain greatly increased the ability 
of SPF to stimulate squalene monooxygenase in microsomes, but, paradoxically 
prevented SPF from stimulating cholesterol synthesis in cell culture.  Addition of 
brefeldin A, which disrupts Golgi formation, also abolished the ability of SPF to 
stimulate cholesterol synthesis, supporting a role for the Golgi in SPF function.  
Since squalene monooxygenase is not thought to be rate-limiting with regard to 
cholesterol synthesis, the possibility that SPF might stimulate other enzymes in the 
cholesterol biosynthetic pathway was investigated.  The substitution of 14C-
mevalonate for 14C-acetate completely blocked an SPF-induced 1.5-fold increase in 
squalene synthesis, suggesting that SPF stimulated mevalonate synthesis at HMG-
CoA reductase.  2,3-Oxidosqualene synthesis from 14C-mevalonate remained 
elevated (1.3-fold) with mevalonate demonstrating that SPF also stimulated 
squalene monooxygenase in hepatoma cells.  SPF did not increase HMG-CoA 
reductase or squalene monooxygenase enzyme levels in cells, indicating that SPF 
directly activated these enzymes.  Indeed, addition of purified recombinant SPF to 
rat liver microsomes stimulated HMG-CoA reductase by about 1.5-fold.  These 
results reveal that SPF directly stimulates HMG-CoA reductase, the rate-limiting 
step of the cholesterol biosynthetic pathway, as well as squalene monooxygenase, 
and, coupled with the ability of PKA-mediated phosphorylation to regulate SPF 
activity, suggest a new means by which cholesterol synthesis can be rapidly 
modulated in response to hormonal and environmental signals.   
 
 Key words:  Supernatant protein factor, cholesterol synthesis, squalene 
monooxygenase, phosphorylation, protein kinase A. 
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CHAPTER ONE 
BACKGROUND 
 
Squalene Monooxygenase 
 
 The biosynthetic pathway for cholesterol from acetate is relatively well 
characterized (Figure 1.1), although its regulation beyond HMG-CoA reductase is 
relatively unknown despite its importance in mammalian physiology.  An increase in 
serum cholesterol levels in humans is associated with the development of 
cardiovascular diseases.  Despite the bad reputation of cholesterol, it is essential for a 
number of physiological processes, including the maintenance membrane integrity, the 
production of bile acids, and the formation of steroid hormones.  The synthesis of 
squalene, a key intermediate, requires five steps and is often referred to as the 
mevalonate, or the isoprenoid synthesis pathway.  This pathway also yields geranyl 
pyrophosphate which in turn yields geranylgeranylated proteins like Rab and Rho and 
farnesyl pyrophosphate, as well as ubiquinone, dolichol, HEME a and farnesylated 
proteins like Ras.  These proteins are essential for a variety of cell functions such as 
vasoconstriction, apoptosis, and immune function.   Squalene monooxygenase 
catalyzes the second step in this committed pathway for cholesterol synthesis.  This 
pathway yields only cholesterol in animal somatic cells, ergosterol in yeast, and 
phytosterols in plants.   Squalene monooxygenase is common to all sterol synthesis 
pathways and catalyzes the epoxidation of squalene to 2,3-oxidosqualene, which is also 
the first oxygenation step in the sterol biosynthetic pathway.    
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Figure 1.1 Cholesterol biosynthetic pathway. 
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Biochemistry and Molecular Biology of Squalene Monooxygenase 
 
 Squalene monooxygenase (EC 1.14.99.7; earlier called squalene epoxidase) is a 
64-kDa flavin adenine dinucleotide (FAD)-containing enzyme bound to the endoplasmic 
reticulum of eukaryotic cells.  The enzyme catalyzes the epoxidation of squalene across 
a C=C double bond utilizing NADPH and oxygen to yield 2,3-oxidosqualene (Yamamoto 
and Bloch 1970).  Squalene monooxygenase resembles cytochrome P450 in its 
reaction chemistry and is dependant upon NADPH- cytochrome P450 reductase for 
reducing equivalents (Ono, Takahashi et al. 1980).  Squalene monooxygenase is not a 
P450: Squalene monooxygenase is not inhibited by typical P450 inhibitors like carbon 
monoxide and metyrapone.  In addition, it also shows no absorption at 450 nm 
(Yamamoto and Bloch 1970; Ono and Bloch 1975).  
 
 Squalene monooxygenase requires NADPH- cytochrome P450 reductase (CPR) 
for its activity.  CPR is responsible for the transfer of electrons from NADPH to a variety 
of enzymes, chiefly the cytochromes P450.  CPR is a flavin containing enzyme, like 
squalene monooxygenase, having one molecule of FAD and FMN.  The FAD of CPR 
accepts two electrons from NADPH in the form of a hydride ion.  The electrons are then 
transferred in sequential fashion to the FMN before being donated to CPR’s redox 
partner, in this case squalene monooxygenase.  In the squalene monooxygenase 
system the two electrons move from CPR to the FAD in squalene monooxygenase and 
are used to reduce one atom of molecular oxygen to water.  The other oxygen atom is 
then inserted across the double bond (C=C) to form the product 2,3-oxidosqualene. 
 
 In addition to CPR and NADPH, squalene monooxygenase requires a 
microsomal supernatant component.  The  supernatant requirement was found to 
consist of three different components: a soluble protein called supernatant protein factor 
(SPF), phospholipids, and FAD (Tai and Bloch 1972).  Ono and Bloch in 1975 published 
that supernatant protein factor could be replaced by the non-ionic detergent Triton X-
100, and that this detergent stimulated the squalene monooxygenase reaction.  SPF 
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has no effect in the presence of this detergent, suggesting that SPF requires an intact 
membrane for activity.   
 
Regulation of Squalene Monooxygenase 
 
The enzyme squalene monooxygenase is considered a important enzyme in the 
cholesterol biosynthetic pathway because of its low specific activity; lower than that of 3-
hydroxy-3methylglutaryl CoA reductase (HMGR) and squalene synthase (Sakakibara, 
Watanabe et al. 1995).  This suggests that squalene monooxygenase might be the rate- 
limiting step in the cholesterol biosynthetic pathway and thus an important regulatory 
point; indeed oxysterols and low density lipoproteins (LDLs) have been shown to 
decrease squalene monooxygenase activity in cultured hepatoma cells apotential form 
of feedback regulation (Hidaka, Satoh et al. 1990).  The same authors also reported that 
the inhibition of HMG-CoA reductase, which is the initial regulatory enzyme for the 
cholesterol biosynthetic pathway, increased squalene monooxygenase activity (Hidaka, 
Satoh et al. 1990).  Similar data was also obtained from animal studies (Satoh, Hidaka 
et al. 1990).  It was also discovered that inhibition of squalene monooxygenase by NB-
598 (a specific inhibitor of squalene monooxygenase) resulted in a decrease in 
secretion of cholesterol, triacylglycerol, and apolipoprotein B from HepG2 cells (Horie, 
Hayashi et al. 1993).  Recent DNA micro-array expression analysis has also revealed 
that squalene monooxygenase was one of the enzymes in the cholesterol biosynthetic 
pathway, along with HMG-CoA reductase, whose expression was suppressed in human 
fibroblasts within 4h after serum addition (Iyer, Eisen et al. 1999).  Recent evidence also 
points to the fact that the squalene monooxygenase gene has a sterol response 
element (SRE) site and a site for another ubiquitous factor called nuclear factor Y (NF-
Y) present in its promoter element.  This adds to the growing evidence that suggests 
that the gene for squalene monooxygenase is under the control of sterol response 
element-binding protein (SREBP) and that this factor can regulate its expression. Since 
this enzyme is a major player in the post-squalene pathway, it has evoked considerable 
interest as a therapeutic target for lowering low-density lipoprotein (LDL) cholesterol, 
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which is a high risk factor in cardiovascular disease and especially coronary heart 
disease. 
 
Supernatant Protein Factor (SPF) 
 
 The properties of squalene monooxygenase have been studied extensively by 
Bloch and colleagues with the use of rat liver microsomes.  In 1957 they reported that 
microsomal squalene monooxygenase activity was increased by addition of rat liver 
105000xg supernatant (Tchen and Bloch 1957).  They later went on to show that the 
supernatant fraction contributes both a heat-labile protein and heat-stable small 
molecules for the monooxygenase system (Yamamoto and Bloch 1970).  Around 1970 
the heat stable factors were identified as being FAD, phosphatidylserine and 
phosphatidylglycerol, while the heat-labile factor was shown to be a 47 kDa protein 
which was trypsin-sensitive; this protein was purified by a factor of 11000 and called  
“supernatant protein factor” (SPF) (Tai and Bloch 1972).  These same researchers also 
noted that SPF would not stimulate squalene monooxygenase when it was solubilized 
and partially purified; this suggested that SPF is effective only with the microsomal 
enzyme.  Bloch and colleagues also demonstrated that SPF promoted transfer of 
squalene across membranes in vitro, which led to the hypothesis that SPF facilitates the 
access of a hydrophobic substrate, in this case squalene, to a site on squalene 
monooxygenase (Friedlander, Caras et al. 1980).  All the above observations suggested 
that SPF could possibly play a role in cholesterol biosynthesis or homeostasis in vivo. 
 
 Supernatant protein factor also activates the second enzyme in the pathway from 
squalene to lanosterol, oxidosqualene cyclase (Caras and Bloch 1979).  The activation 
conditions for this enzyme differ from those of squalene monooxygenase in that the 
phospholipids can be substituted by phosphatidylethanolamine (Caras and Bloch 1979).  
Oxidosqualene cyclase is suggested to be associated with the luminal surface of the 
microsomal membrane and thus is not directly associated with the cytosol or SPF.  The 
above findings supported the argument that SPF may facilitate the transfer of squalene 
and oxidosqualene between membrane compartments.  SPF has not been shown to 
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activate any of the other downstream enzymes in the cholesterol pathway, suggesting 
that it is specific for the squalene-to-lanosterol steps.  The enzymes activated by SPF 
are shown in Figure 1.2. 
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Figure 1.2 Enzymes stimulated by SPF. 
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SPF and Lipid Transfer Proteins 
 
Studies on SPF have been dormant for the last two decades, and no information 
was forthcoming till 2001. Shibata et al. in 2001 cloned cDNAs for rat and human SPF 
(Shibata, Arita et al. 2001).  Both rat and human SPF cDNAs encoded a 403 amino 
acid, 47 kDa protein.  Rat and human SPF share  94% sequence identity and are 
abundantly expressed in the liver and intestine (Shibata, Arita et al. 2001).  Comparison 
of SPF to the BLAST and protein database suggested that SPF belonged to a family of 
lipid binding/transfer proteins (Figure 1.3).  SPF shows significant homology to α-
tocopherol transfer protein, cellular retinal-binding protein and yeast sec14p. Exact roles 
of all these proteins are nebulous.  Sec14p is a yeast protein which exhibits 
phosphatidylinositol/phosphatidylcholine transfer activity and is required for protein 
secretion through the Golgi complex.  Cellular retinal-binding protein is involved in the 
binding of 11-cis-retinal in the mammalian visual system, and α-tocopherol transfer 
protein (α-TTP) specifically binds α-tocopherol (vitamin E) and is thought to be involved 
in regulating serum vitamin E levels.  All of these proteins contain a 185-amino acid 
CRAL/TRIO domain and it is this domain, which seems to be involved in the lipid 
binding.  SPF in addition contains a 157-amino acid extension on the C-terminus 
(Figure 1.3), which may bind GTP.  Two segments of SPF, between 34-48 and 206-209 
are especially highly conserved in this group of proteins.  The region between these 
amino acids is probably the ligand-binding domain. SPF surprisingly also shows  77% 
identity to a protein isolated from rat olfactory epithelium (Merkulova, Andreeva et al. 
1999).  This SPF-like protein binds GTP and was identified on the basis of a GTP-
binding domain at the beginning of the C-terminus.  SPF also shares the same GTP-
binding motif as mentioned above.  The role of this olfactory SPF-like protein and its 
relation to cholesterol in the olfactory epithelium remains a mystery. Panagabko et al. 
showed that human SPF had the highest affinity for phosphatidylinositol relative to 
phospholipids and other related compounds (Panagabko, Morley et al. 2003).  In 
addition Stocker et al. have also shown that SPF binds to RRR-alpha-
tocopherylquinone, the major physiological oxidation product of RRR-alpha-tocopherol 
(Stocker and Baumann 2003).  
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Figure 1.3 The CRAL-TRIO protein family 
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Crystal Structure of Human SPF 
 
 In 2002 Stocker et al. published the crystal structure of supernatant protein 
factor.  The structure of SPF consists of 13 β-strands, 11 α-helices, and 8 310-helices.  
This structure bears similarity to the yeast Sec14p protein.  SPF folds into two domains: 
the N-terminal domain consists of 275 residues which form a Sec14-like domain and the 
C-terminal 115 residues form a eight stranded jelly-roll “barrel” (Stocker, Tomizaki et al. 
2002).  The central β sheet in the N-terminal domain forms one side and helices 6-10 on 
the other side enclose a large hydrophobic ligand binding pocket.  The entrance to the 
ligand-binding pocket is blocked by the helices 9-10 and a connecting loop.  The C-
terminal residues 290-403 fold into an eight stranded anti-parallel β sandwich consisting 
of two four-stranded anti-parallel β sheets.  The exact function of this domain is 
unknown but has been suggested to bind to cell membranes (Anantharaman and 
Aravind 2002). The representative crystal structure of SPF along with its various 
domains and ligand is shown in Figure 1.4. 
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Figure 1.4 Crystal structure of human SPF 
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SPF and the GOLD-Domain 
 
 The carboxyl-terminal domain of SPF (amino acids 290 to 403) shows 
sequence similarity to proteins involved in Golgi function, including the p24 family, 
which are involved in coated vesicle transport from the endoplasmic reticulum to 
Golgi (Anantharaman and Aravind 2002).  This domain is not found in other lipid 
transfer proteins in the CRAL/TRIO family, including Sec14p and α-tocopherol 
transfer protein.  This domain is called the GOLD (Golgi dynamics) domain.  The 
GOLD-domain proteins can be divided into two categories; Category 1 wherein the 
proteins are anchored in the membrane by a membrane spanning helix, and 
category 2, wherein the GOLD-domain occurs at the extreme carboxyl or amino 
terminus, along with other domains that are known to interact with lipid membranes.  
SPF belongs to the second category.  The same authors suggest that SPF and 
SPF-like proteins could function as double-headed adaptors or vesicular cargo-
loading molecules and interact with specific proteins as well as lipid membranes.  
The exact role of this domain in SPF remains to be determined. 
 
SPF and Tocopherol Associated Protein (TAP) 
 
 In 2000 Zimmer et al. described the identification, molecular cloning, and in vitro 
expression of human tocopherol associated protein (TAP).  They described this protein 
to be a part of the ligand-binding proteins which have a CRAL motif in common.  The 
proposed role of this protein was that it was a vitamin E binding protein.  This binding 
protein would hypothetically function to transfer α-tocopherol from chylomicrons via liver 
into blood plasma (Zimmer, Stocker et al. 2000).   Surprisingly, the protein described as 
TAP has the same amino-acid sequence as SPF.  Though the exact functions of TAP 
have not yet been determined, latest evidence has suggested that TAP is a ligand-
dependent transcriptional activator (Yamauchi, Iwamoto et al. 2001).  TAP binds to 
binds to the biotinylated form of α-tocopherol with a KD of 0.46 µM. Other forms of 
vitamin E show much less affinity for TAP (Yamauchi, Iwamoto et al. 2001).   TAP fused 
with a green fluorescent protein (GFP), was shown to translocate from the cytosol to the 
nucleus in an α-tocopherol dependent manner.  Transient transfections of GAL4-DNA-
 13
binding domain/TAP fusion protein activates the GAL-dependent luciferase gene in an 
α-tocopherol dependent manner (Yamauchi, Iwamoto et al. 2001).  All the above results 
suggest that TAP (SPF) is a transcription factor. 
 
SPF, Gene Transcription, and Cholesterol Synthesis 
 
From the data present in the literature it is clear that SPF increases the activation 
of squalene monooxygenase in vitro, and it has been postulated that SPF transfers 
squalene into, within, or between membranes. However, high-affinity squalene binding 
has not been demonstrated.  SPF increases cholesterol biosynthesis when expressed 
in hepatoma cells (Shibata, Arita et al. 2001).  Nagai et al. have also demonstrated that 
SREBP-2 and NF-Y are involved in the transcriptional regulation of squalene 
monooxygenase (Nagai, Sakakibara et al. 2002).  It is possible that SPF is a 
transcription factor involved at some level in the cholesterol biosynthetic pathway.  This 
could be due to direct activation of the gene for squalene monooxygenase, or it could 
be via the sterol response element-binding proteins (SREBPs), especially SREBP-2, 
which appears to be involved in the transcriptional regulation of squalene 
monooxygenase.  There is also the possibility that SPF could be activating other 
enzymes in the cholesterol biosynthetic pathway in addition to squalene 
monooxygenase.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Vishwesh Mokashi 2004 
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CHAPTER 2 
 
CLONING AND PURIFICATION OF HUMAN SUPERNATANT PROTEIN FACTOR 
(hSPF) 
 
Cloning and Expression of hSPF  
The hSPF cDNA was amplified with Pfu polymerase (Stratagene) from a human 
liver cDNA library (Quick-Clone, Clontech) with primers based on the reported human 
SPF sequence (Shibata, Arita et al. 2001) and that incorporated an NcoI restriction site 
at the translation start codon and an XhoI restriction site immediately following the stop 
codon (Figure 2.1, Lane 2). The amplification product was cloned into the PCR-BLUNT 
II TOPO vector (Invitrogen), plasmid DNA was isolated, and the sequence of the insert 
was determined at the Molecular Structure and Analysis Facility, University of Kentucky, 
to confirm identity with SPF. The SPF cDNA insert was released with NcoI and XhoI, 
purified by agarose-gel electrophoresis, and cloned into the pTYB4 expression vector 
(New England Biolabs). SPF protein was purified following the protocol for expression of 
intein fusion proteins with the IMPACT T7 system as follows. SPF expression was 
induced in E. coli ER2566 cells overnight with 1 mM isopropyl-β-D-
thiogalactopyranoside at 30 °C with slow shaking. All subsequent steps were carried out 
at 4 °C. Cells were broken in a French pressure cell in buffer containing 20 mM Tris-HCl 
(pH 7.4), 500 mM NaCl, and 0.1 mM EDTA, and the lysate was cleared by 12,000 × g 
centrifugation for 30 min followed by digestion with 1 µg of DNA nuclease for 1 h. The 
cleared lysate was loaded onto a chitin affinity column (2-ml bed volume), washed with 
40 ml of lysis buffer, and incubated overnight at 4 °C in 4 ml of buffer containing 30 mM 
β-mercaptoethanol to promote cleavage of the intein-SPF bond. SPF was eluted with 
10-20 ml of the same buffer, which was then replaced by centrifugal dialysis with 20 mM 
Tris-HCl, pH 7.4, and the sample was stored at 80 °C. The purified protein retains four 
amino acids (Leu-Glu-Pro-Gly) at the C terminus that are derived from the intein fusion 
sequence.   The scheme of purification is shown in Figure 2.2. 
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Figure 2.1 Agarose gel of amplified hSPF clone. 
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Figure 2.2 Scheme of purification of hSPF by chitin column. 
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Results 
 
 Cloning and Purification of Human SPF — The published sequence of human 
SPF (Shibata, Arita et al. 2001) was used to design primers for the amplification of SPF 
from a human liver cDNA library (Figure 2.1, lane 2). The resulting cDNA exhibited two 
differences from the published sequence: at codon 2, where incorporation of an NcoI 
site into the primer to facilitate cloning replaced a serine with glycine; and at codon 
11, where a lysine was encoded instead of arginine. A lysine is also found at this latter 
position in the rat sequence (Shibata, Arita et al. 2001). Expression and purification of 
SPF from E. coli yielded a largely homogeneous protein that migrated at 45 kDa, 
consistent with the predicted molecular mass of 47 kDa (Figure 2.3) 
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Figure 2.3 SDS–polyacrylamide gel electrophoresis of bacterially expressed SPF. 
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CHAPTER 3 
 
RAT SUPERNATANT PROTEIN FACTOR-LIKE PROTEIN (SPF2) 
 
Introduction to Rat SPF2 
 
There are three SPF-related genes in the human genome, sharing 70–77% 
identity in encoded protein sequences (GenBank Accession Nos. NP_036561, 
NP_777635, and NP_777637). cDNAs corresponding to all three genes have been 
cloned (Zimmer, Stocker et al. 2000; Shibata, Arita et al. 2001; Yamauchi, Iwamoto et 
al. 2001; Kempna, Zingg et al. 2003; Singh, Mokashi et al. 2003), but only one has been 
characterized with regard to its ability to stimulate squalene epoxidation (Singh, 
Mokashi et al. 2003). This protein also corresponds to tocopherol-associated protein. In 
the rat, two SPF proteins have been identified and cloned (Novoselov, Peshenko et al. 
1996; Shibata, Arita et al. 2001). Whereas one corresponds to the traditional SPF 
protein first characterized by Bloch and colleagues (Tai and Bloch 1972; Ferguson and 
Bloch 1977; Shibata, Arita et al. 2001), the second protein, rat secretory protein, was 
identified as a potential G-protein subunit based on its reactivity with an antibody to the 
α-subunit of G-proteins (Merkulova, Andreeva et al. 1999). The cDNA sequence of rat 
secretory protein subsequently revealed that it was not an α-subunit, although it could 
be photolabeled with GTP (Merkulova, Andreeva et al. 1999). This protein is highly 
expressed in epithelial tissues, including those from the olfactory bulb, trachea, lung, 
and skin (Merkulova, Andreeva et al. 1999). The human homolog is expressed in lung 
tissue but is less evident in skin. No function has yet been assigned to this protein. 
 
To determine if this second rat SPF-like protein (SPF2) shared the characteristics of 
SPF, we have cloned and expressed rat SPF2 in Escherichia coli and determined the 
ability to stimulate squalene monooxygenase in vitro. 
 
Experimental Methods 
 
 Cloning and expression of rat SPF2 — A cDNA to SPF2 was amplified with Pfu 
polymerase (Stratagene) from a rat olfactory bulb cDNA library, provided by Dr. Xinxin 
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Ding (New York State Department of Health). Primers were based on the published rat 
SPF2 sequence (Merkulova, Andreeva et al. 1999), and incorporated an NdeI restriction 
site at the translation start codon and an XhoI restriction site immediately after the stop 
codon. The amplification product was ligated into the PCR-BLUNT II TOPO vector 
(Invitrogen), plasmid DNA was prepared, and the sequence of the insert was 
determined at the Molecular Structure and Analysis Facility, University of Kentucky. This 
sequence confirmed its identity with the published sequence of rat SPF2 (Merkulova, 
Andreeva et al. 1999), GenBank Accession No. AJ132352. The SPF2 cDNA was 
released with NdeI and XhoI, purified by agarose gel electrophoresis, and ligated into 
the pTYB2 expression vector (New England Biolabs). SPF2 protein was purified from E. 
coli ER2566 cells following the protocol for expression of intein-fusion proteins with the 
IMPACT T7 system as described previously (Singh, Mokashi et al. 2003). The purified 
protein retains four amino acids (Leu–Glu–Pro–Gly) at the C-terminus, which are 
derived from the intein-fusion protein sequence. The elution buffer was replaced with 
20 mM Tris–HCl, pH 7.4, by centrifugal dialysis, protein was quantified with Coomassie 
Plus reagent (Pierce), and the sample was stored at -80 °C.  
Squalene monooxygenase activity assays — Squalene monooxygenase activity 
assays were carried The microsomal fraction (100,000 × g pellet, ~15 mg of protein/ml) 
and cytosolic fraction (100,000 × g supernatant, ~20 mg of protein/ml) were prepared 
from the livers of untreated male Harlan Sprague-Dawley rats (~200 g) by standard 
procedures. Animals were maintained on a normal light-dark cycle with free access to 
rat chow and were killed in late morning by decapitation.  200 µg of microsomal protein, 
30 µM FAD, 40 µM [14C]squalene, 10 µg of phosphatidylglycerol, and 0.3 mM AMO 
1618 (Calbiochem) to inhibit oxidosqualene cyclase in 200 µl of 20 mM Tris-HCl buffer, 
pH 7.4, with 1 mM EDTA. Reactions were started by the addition of NADPH to 1 mM, 
incubated in a 37 °C water bath for 1 h, and were stopped by the addition of 0.5 ml of 
10% KOH in methanol after the incubation volume was brought to 1 ml with water. The 
tubes were capped, and after saponification at 80 °C for 1 h the neutral lipids were 
extracted with 3 ml of petroleum ether. The solvent was removed under evaporative 
centrifugation, and the lipids were resuspended in 50 µl of the same and spotted onto 
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silica thin-layer plates. Lipids were fractionated in 5% ethyl acetate in hexane and 
visualized and quantified by electronic autoradiography (Packard Instant Imager). 
Radiolabeled squalene (14C) was synthesized by the Chemical Synthesis Facility, 
Department of Medicinal Chemistry, University of Utah, at 7 mCi/mmol. 
The effect of nucleotides and α-tocopherol on the ability of SPF2 to stimulate squalene 
monooxygenase was determined either by preincubating 5 µg of SPF2 with 3 mM 
nucleotide (ATP, GTP or GDP) or 50 µM α-tocopherol for 30 min at 37 °C, or by adding 
these potential ligands directly to the SPF2/microsomal incubations at the final 
concentrations indicated above. All nucleotide incubations included 4.5 mM MgCl2. 
Unbound nucleotide or α-tocopherol was removed from the preincubations by 
centrifugal filtration using Microcon concentrators (30 kDa cutoff) and SPF2 protein was 
resuspended in 20 mM Tris buffer, pH 7.4, and added to squalene monooxygenase 
reactions as described above.  
Activation of SPF2 by protein kinases — The ability of protein kinases A and C 
(PKA, PKC) to activate SPF2 was determined with 5 U of mouse recombinant catalytic 
PKA subunit Cδ, (Calbiochem) or 0.25 U of human recombinant PKC isozyme δ, 
(Calbiochem), according to the supplier's instructions.  The reaction mixture for PKA 
included 3mM ATP, 1mM cAMP and 200mM Tris buffer.  The reaction mixture for PKCδ 
consisted of 3mM ATP, activator solution containing phosphatidylserine and 
diacylglycerol (3mg/ml) and 200mM Tris buffer containg 5mM calcium chloride and 
100mM magnesium chloride. Each kinase was incubated with purified recombinant 
SPF2 for 30 min at 30°C.  Following the incubation of each kinase with recombinant 
SPF2 (5 µg) at 30 °C for 30 min, the ability of each mixture to stimulate squalene 
monooxygenase was determined as described above. The effect of nucleotides (3 mM 
GTP or GDP) and α-tocopherol (50 µM) on the activation of SPF2 by PKA and PKCδ 
was determined by adding these substances to the preincubations. 
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Results 
 
 Cloning and purification of rat SPF2 — The published sequence of rat SPF2 
(Merkulova, Andreeva et al. 1999) was used to design primers for the polymerase-chain 
amplification of an SPF2 cDNA from a rat olfactory bulb cDNA library. The resulting 
cDNA was identical to the reported sequence (GenBank Accession No. AJ132352) 
(Merkulova, Andreeva et al. 1999) with the addition of four amino acids (Leu–Glu–Pro–
Gly) encoded at the C-terminus as a result of the cloning strategy. The expression and 
purification of SPF2 from E. coli yielded a homogeneous protein that migrated slightly 
more slowly than human SPF, consistent with its predicted molecular mass of 45 kDa 
(Figure 3.1).  
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Figure 3.1 SDS–polyacrylamide gel electrophoresis of bacterially expressed SPF 
and SPF2. The purified proteins were loaded onto a 10% SDS–polyacrylamide gel and 
after electrophoresis the gel was stained with Coomassie blue. Lane 1, SPF2, 3 µg; 
lane 2, SPF, 3 µg; and lane 3, molecular mass markers in kilodalton. 
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Stimulation of squalene monooxygenase by SPF2 — While SPF has long been 
known to stimulate squalene monooxygenase activity in microsomal preparations, a role 
for the more recently identified rat SPF2 protein has not been established.  It is also 
important to mention that rat SPF1 acts to stimulate squalene monooxygenase in vitro 
(Shibata, Arita et al. 2001). To determine if SPF2 could also stimulate squalene 
monooxygenase, increasing amounts of the purified protein, ranging from 0.01 to 
1.6 µg, were added to rat liver microsomes and squalene monooxygenase activity was 
determined (Figure 3.2). Maximum stimulation of monooxygenase activity was obtained 
with 0.8 µg of recombinant rat SPF2 protein, a value identical to that determined for 
maximal activity of recombinant human SPF (Singh, Mokashi et al. 2003). The 
stimulatory effect was lost with higher concentrations of SPF2, as was also seen with 
SPF (Singh, Mokashi et al. 2003). The maximal stimulation by SPF2 was only about 
50% of that obtained with human SPF.  
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Figure 3.2 Stimulation of microsomal squalene monooxygenase by recombinant 
SPF2. Squalene monooxygenase activity in rat liver microsomes was determined over 
60 min, in the absence (control) or presence of the indicated amounts of SPF2. SPF 
was used at 0.8 µg. Each value represents the mean ± SE of two separate experiments 
carried out in duplicate. 
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Effect of various nucleotides on SPF2 — SPF2 purified from rat olfactory tissue 
has been reported to bind GTP (Novoselov, Peshenko et al. 1996), and both SPF and 
rat SPF2 contain a putative GTP-binding motif at the C-terminus (Porter 2003). SPF has 
also been reported to bind α-tocopherol (Zimmer, Stocker et al. 2000; Yamauchi, 
Iwamoto et al. 2001; Panagabko, Morley et al. 2003). To determine if nucleotides or α-
tocopherol affected the ability of SPF2 to stimulate squalene monooxygenase, 3 mM 
ATP, GTP or GDP or 50 µM α-tocopherol was added to SPF2 preparations. GTP and 
GDP prevented the stimulation of squalene monooxygenase by SPF2, suggesting that 
binding of these nucleotides inhibits SPF2. This inhibition could be prevented by the 
addition of α-tocopherol, although α-tocopherol alone had no effect on SPF2 activity. 
These effects were seen when the putative ligands were added in preincubations and 
when they were added directly to the microsomal assays (Figure 3.3). GTP and GDP 
had no effect on squalene monooxygenase activity in the absence of SPF2. 
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Figure 3.3 Putative SPF ligands affect SPF2 activity.  The ability of various 
nucleotides (3 mM) and α-tocopherol (50 µM) to affect SPF2 activity was determined by 
monitoring the ability of the treated preparations to stimulate microsomal squalene 
monooxygenase activity.  Each value represents the mean ± SE of two experiments 
carried out in duplicate.   Open bars, preincubation of nucleotides with SPF2; closed 
bars, addition of the nucleotide or α-tocopherol (αT) directly to the microsomal assay. 
Control indicates microsomes with no SPF2 added 
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Activation of SPF2 by protein kinases — Human SPF is activated approximately 
twofold by PKA and PKCδ (Singh, Mokashi et al. 2003). To determine if rat SPF2 is 
similarly activated by these kinases, purified SPF2 was incubated with PKA and PKCδ 
in the presence of ATP (Figure 3.4). PKA increased SPF2 activity by approximately 
twofold, but PKCδ was less effective. The addition of these protein kinases to 
microsomes alone did not increase squalene monooxygenase activity, indicating that 
the stimulation provided by these kinases was due to an effect on SPF2. These results 
suggest that rat SPF2 is activated by protein kinase A in a manner similar to that of SPF 
and that this activation is presumably mediated by phosphorylation of one or more 
specific serines or threonines. The addition of GTP, GDP, or α-tocopherol had no effect 
on the activation of SPF2 by these kinases (data not shown).  
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Figure 3.4 Activation of SPF2 by protein kinases.  Purified recombinant SPF2 was 
incubated in the absence or presence of the indicated protein kinases and ATP, and the 
ability of the preparations to stimulate microsomal squalene monooxygenase was 
determined.  PKA, protein kinase A; PKCδ, protein kinase C, δ isoform; and control, no 
SPF2 added. Each value represents the mean ± SE of two experiments carried out in 
duplicate. 
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Discussion 
 
 There are three SPF genes in human and at least two in both rat and mouse, but 
the physiological role of these proteins remains controversial. Proposed functions 
include shuttling squalene into and between intracellular membranes, transferring α-
tocopherol between compartments in the cell, activating gene transcription in response 
to α-tocopherol, and modulating phosphatidylinositol-3-kinase activity. In this study we 
have cloned, expressed, purified, and assigned a possible function to one of these SPF-
like proteins found in the rat. This rat supernatant protein factor-like protein, designated 
SPF2, shares 77% and 90% sequence identity with human and rat SPF, respectively, 
including a GTP-binding motif as indicated by photoaffinity labeling of SPF2 (Novoselov, 
Peshenko et al. 1996; Merkulova, Andreeva et al. 1999), also rat SPF is known to 
stimulate squalene monooxygenase in vitro (Shibata, Arita et al. 2001). Unlike SPF, this 
protein and its human homolog appear to be expressed predominantly in respiratory 
and epithelial tissue (Novoselov, Peshenko et al. 1996; Merkulova, Andreeva et al. 
1999; Kempna, Zingg et al. 2003), and a role for this protein has not yet been 
described. Our studies demonstrate that SPF2 is approximately 50% as effective as 
SPF in stimulating squalene monooxygenase activity, and, like SPF, could be activated 
by protein kinase A. While this suggests that SPF2 may also be involved in regulating 
cholesterol synthesis, its lesser activity relative to SPF and the greater degree of 
inhibition by GTP and GDP raise the possibility that this protein has other roles in the 
cell.  
Recent studies by Kempna et al. (Kempna, Zingg et al. 2003) demonstrated that all 
three human SPF proteins bind tocopherols, phosphatidylinositol, phosphatidylcholine, 
and phosphatidylglycerol, and this group postulated that these proteins modulate, in a 
tocopherol-sensitive manner, phosphatidylinositol-3-kinase activity. Concurrent studies 
done by Panagabko et al. (Panagabko, Morley et al. 2003) on the ligand-specificity of 
CRAL-TRIO protein family members including Sec14p, cellular retinal binding protein, α-
tocopherol transfer protein (α-TTP), and SPF have suggested that the binding of 
tocopherols to SPF may not be physiologically relevant. They observed that there is a 
considerable amount of ligand promiscuity among the CRAL-TRIO protein family 
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members, but that only α-TTP binds α-tocopherol with sufficient avidity to support its 
role as a physiological mediator of α-tocopherol's biological activity (Panagabko, Morley 
et al. 2003). However, a more recent study suggests that SPF preferentially binds α-
tocopherylquinone, the principal physiological oxidation product of α-tocopherol (Stocker 
and Baumann 2003). It should be noted that the affinity of SPF for squalene is similarly 
low, calling into question whether squalene is truly a ligand for SPF; interestingly, SPF 
shows greatest affinity for phosphatidylinositol (Panagabko, Morley et al. 2003), and 
anionic phospholipids (such as phosphatidylinositol) have long been known to increase 
microsomal squalene monooxygenase activity, both in the presence and absence of 
SPF (Tai and Bloch 1972). The binding affinities of SPF2 have not been determined, but 
Kempna et al. (Kempna, Zingg et al. 2003) showed that human SPF2 could bind α-
tocopherol and squalene, as well as phosphatidylinositol.  
To further complicate SPF biochemistry, the carboxylterminal domain, earlier suggested 
to be a GTP-binding domain, has recently been shown to bear significant similarity to a 
GOLD (Golgi dynamics) domain (Anantharaman and Aravind 2002; Kempna, Zingg et 
al. 2003). This domain is present in a number of proteins involved in Golgi function, and 
is predicted to mediate protein–protein interactions involved in assembly of membrane-
associated complexes and Golgi function (Anantharaman and Aravind 2002). It has also 
been reported that SEC14p-like proteins including human SPFs share homology to 
domains found in GTPase activating proteins (GAPs) and guanine nucleotide exchange 
factors (GEFs), which suggests a link between the binding of lipids by SEC14p-like 
proteins and regulation of Ras and Rho GTPases (Aravind, Neuwald et al. 1999). These 
apparently diverse actions of SPF-like proteins, coupled with the demonstration herein 
that SPF2 is, like SPF, able to stimulate squalene monooxygenase in vitro, suggest 
these proteins may serve multifunctional roles in the cell, perhaps on a tissue-specific 
basis.  
The presence of a putative GTP-binding motif in the carboxylterminal domain of SPF2 
raised the possibility that GTP or other nucleotides might modulate the activity of this 
protein. The addition of GTP or GDP blocked the ability of SPF2 to stimulate squalene 
epoxidation, but activity could be maintained by the inclusion of α-tocopherol. Similar 
studies with human SPF revealed a slight inhibition of activity with GTP, and a weak 
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ability of GTP and GDP to reduce SPF activity in rat liver cytosol (Mokashi, Singh et al. 
2004).  The addition of these nucleotides to incubations with PKA and PKC did not 
affect the activation of SPF2 by these kinases. These results indicate that SPF2 activity 
may be modulated by guanine nucleotides, and are consistent with studies that reported 
that this protein binds GTP and has weak GTP hydrolase activity (Novoselov, Peshenko 
et al. 1996; Kempna, Zingg et al. 2003). The ability of α-tocopherol to block this 
inhibition is intriguing; α-tocopherol has been shown to promote the movement of SPF 
(termed TAP, tocopherol-associated protein) from the cytosol to the nucleus to activate 
reporter gene transcription (Yamauchi, Iwamoto et al. 2001), and α-tocopherol binding 
to TAP has been shown to stimulate its ability to activate phosphatidylinositol 3-kinase 
(Kempna, Zingg et al. 2003).  
Protein kinases A and Cδ were found previously to increase the ability of SPF to 
stimulate squalene monooxygenase activity; other serine/threonine kinase isoforms 
demonstrated a lesser ability to activate SPF (Singh, Mokashi et al. 2003). Addition of 
PKA to SPF2 yielded a 1.5-fold increase in the activity of this protein, somewhat less 
than the twofold stimulation of SPF obtained with PKA and PKCδ (Singh, Mokashi et al. 
2003). PKCδ was also less effective with SPF2.  
 In summary rat SPF2 mimics the action of human SPF in an in vitro system.    
The mechanism by which phosphorylation activates this protein remains to be 
determined. 
 
 
 
 
 
 
 
 
 
Copyright © Vishwesh Mokashi 2004 
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CHAPTER 4 
 
INVOLVEMENT OF PHOSPHORYLATION, AND INTERACTION WITH GOLGI FOR 
THE SPF-MEDIATED INCREASE IN CHOLESTEROL SYNTHESIS IN RAT 
HEPATOMA CELLS 
 
Introduction 
 
SPF differs from other CRAL/TRIO proteins (Sec14p, α-tocopherol transfer 
protein, cellular retinal binding protein) in that it contains a 157-amino acid carboxyl-
terminal extension that bears significant similarity to the Golgi dynamics domain 
found in a number of proteins involved in Golgi function (Anantharaman and Aravind 
2002; Kempna, Zingg et al. 2003).  SPF proteins appear to associate with Golgi and 
endoplasmic reticular membranes (Kempna, Zingg et al. 2003), and, although Golgi 
do not contribute to cholesterol synthesis, they are responsible for moving newly 
synthesized cholesterol to the cell surface (Simons and Ikonen 2000).  Recent 
studies from our laboratory revealed that SPF is activated by protein kinases A 
(PKA) and C (PKC), and that the activated protein increases squalene 
monooxygenase activity in vitro by 2-fold over that obtained with unphosphorylated 
SPF, and 6-fold over that obtained in the absence of SPF (Singh, Mokashi et al. 
2003).  The present studies were undertaken to determine if this protein kinase-
mediated activation of SPF could also be observed in cells in culture through a 
stimulation of cholesterol synthesis.  The role of the carboxyl-terminal Golgi 
dynamics domain in SPF-stimulated cholesterol synthesis was also evaluated by 
deletion analysis and by the use of brefeldin A, which disrupts Golgi function.  
Results suggest that SPF can modulate cholesterol synthesis in response to cAMP 
levels, and that Golgi function is a necessary component of this regulation. 
 
Experimental Methods 
Construction and Bacterial Expression of Modified SPF Proteins — The 
codon for serine-289 (TCC), a putative PKA phosphorylation site, was altered in the 
human SPF cDNA to encode alanine (GCC) by site-directed mutagenesis with the 
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QuickChangeTM Kit (Stratagene) and whole-plasmid amplification.  Golgi dynamics 
domain deletion constructs (SPF283, SPF292, and SPF383) were created by 
polymerase chain amplification with appropriate oligonucleotide primers.  All 
mutations and deletions were confirmed by DNA sequence determination on the 
final plasmid construct.  SPF cDNAs were cloned into the pTYB4 expression vector 
(New England Biolabs) and expression in Escherichia coli ER2566 and purification 
was carried out as described previously (Singh, Mokashi et al. 2003).  Centrifugal 
ultrafiltration was used to dialyze and concentrate the eluted proteins in 20 mM Tris 
buffer, pH 7.4.  Protein concentration was determined with the Coomassie Plus 
Assay Reagent Kit (Pierce) and the proteins were stored at -80°C.   
 
Determination of SPF Activity in vitro — The ability of the modified SPF 
proteins to stimulate squalene monooxygenase activity in vitro was determined as 
described in the previous chapter with Sprague-Dawley rat liver microsomes (~15 
mg of protein/ml, 200 µg/reaction) in a final volume of 0.2 ml.  Purified SPF, mutant 
and the deletion construct proteins were added at 0.8µg/reaction.  Incubations of 
SPF with PKA and PKCδ were carried out as described (Singh, Mokashi et al. 
2003), following the supplier’s instructions (Calbiochem).  14C-Squalene was 
synthesized by SRI International (Menlo Park, CA) and used at 7 mCi/mmol.  
Neutral lipids were extracted with 3 ml of petroleum ether, and, after removing the 
solvent by centrifugal evaporation, were resuspended in 50 µl of petroleum ether 
and spotted onto silica thin-layer plates (Whatman).  Lipids were fractionated in 5% 
ethyl acetate in hexane and visualized and quantified by electronic autoradiography 
(Packard Instant Imager).  
 
Determination of Transfected SPF Activity in Hepatoma Cells — The SPF 
cDNAs were cloned into the mammalian expression vector pcDNA3.1 by 
polymerase chain amplification and plasmid DNA prepared from E. coli 
transformants with the Wizard Midipreps DNA Purification System (Promega).  
McARH7777 rat hepatoma cells were plated at a density of 5 × 104 cells per square 
centimeter into 6-well cell-culture plates in 2 ml of Dulbecco’s Modified Eagle’s 
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Medium with 10% fetal bovine serum and 1% penicillin/streptomycin/glutamine 
solution (day 1).  After 24 h the purified plasmid DNA was transfected into the cells 
at 1 µg/well with the use of LipofectAMINE-Plus transfection reagent (Invitrogen).  
Cell viability after transfection (day 4), as assessed by trypan blue exclusion, was 
approximately 80%; transfection efficiency was approximately 70-80%, determined 
by cotransfection of a β-galactosidase expression plasmid.  On days 3 and 4 the 
media was replaced and on day 4 14C-acetate (Amersham Biosciences, 
60mCi/mmol) was added (1 µCi/well) and the cells were incubated at 37ºC for 3 h.  
The media was removed, the cells were washed twice with 1% phosphate-buffered 
saline solution, pH 7.4, harvested by scraping, resuspended in Tris-EDTA buffer, pH 
7.4, containing 0.1% Triton X100, and lysed by sonication three times for 5 s with a 
Sonic Dismembrator (Fisher Scientific) at medium setting.  Lipids were extracted 
with a mixture of chloroform/methanol (2:1), subjected to centrifugal evaporation, 
resuspended in 50 µl of the same and resolved by silica thin-layer chromatography 
in petroleum ether/ethyl ether/acetic acid (60:40:1).  Radiolabeled cholesterol was 
visualized and quantified by electronic autoradiography and authenticated by 
comparison to a cholesterol standard visualized by iodine vapor stain.   
 
Analysis of SPF Protein Expression — The integrity of the bacterially 
expressed SPF mutant proteins (S289A, SPF283, SPF292, and SPF383) was 
assessed by Coomassie blue staining of the purified proteins after fractionation on 
15% sodium dodecyl sulfate–polyacrylamide gels.  The expression of these SPF 
proteins in hepatoma cells was assessed by immunoblotting.  Cells were harvested 
48 h after transfection, lysed by sonication as described above, and the lysate 
cleared by centrifugation at 12,000 x g for 30 min at 4°.  The cleared lysate was 
fractionated by sodium dodecyl sulfate–polyacrylamide gel electrophoresis on 15% 
gels, electrophoretically transferred to nitrocellulose membranes, and probed with 
chicken polyclonal antibody to human SPF.  The immunoblot was developed with a 
secondary antibody conjugated to alkaline phosphatase.  Molecular mass markers 
were obtained from Invitrogen.  The expression levels of the various SPF proteins 
are shown in Figure 4.1. 
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Figure 4.1 Immunoblot of SPF proteins expressed in rat hepatoma cells.  
McARH7777 cells were transfected with the indicated SPF expression plasmids and 
after 48 h cell lysates were prepared and fractionated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis, transferred to nitrocellulose, and immunostained 
using antibody to SPF.  Lane 1, molecular mass markers; Lane 2, purified 
bacterially expressed SPF; Lane 3, lysate from cells transfected with pcDNA3.1 
(note that hepatoma cells do not express endogenous SPF); Lane 4, lysate from 
cells transfected with WT-SPF; Lane 5, lysate from cells transfected with 
SPF(S289A); Lane 6, lysate from cells transfected with SPF383; Lane 7, lysate from 
cells transfected with SPF292; Lane 8, lysate from cells transfected with SPF283. 
Lane 2 was loaded with ~5 µg of protein, lanes 3-8 were loaded with ~20 µg of 
protein. 
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Effect of Dibutyryl-cAMP, PKA Inhibitor, and Brefeldin A on SPF Activity — 
Dibutyryl-cAMP, myristoylated cell-permeable protein kinase A inhibitor 14-22 
amide, and (+)-brefeldin A were purchased from Calbiochem.  Dibutyryl-cAMP was 
added to hepatoma cell cultures at a final concentration of 0.2 mM and the PKA 
inhibitor was added at a final concentration of 1 µM at various times, as indicated, 
prior to the addition of 14C-acetate.  Brefeldin A (100 nM) was added 3 h prior to the 
addition of 14C-acetate.  For the wash-out experiment the media containing the 
brefeldin A was removed after 3 h and cholesterol synthesis was measured after a 
2-h recovery in fresh media.   
 
Results 
Ser-289 is Necessary for the Full Activation of SPF by PKA — Earlier studies 
from our laboratory revealed that human SPF is activated by PKA and PKCδ, 
presumably by phosphorylation on one or more serine or threonine residues (Singh, 
Mokashi et al. 2003).  Sequence comparisons between human and rat SPF 
sequences, including rat SPF2, which is also activated by PKA (Mokashi, Singh et 
al. 2004), revealed a single PKA consensus sequence (Kennelly and Krebs 1991) 
common to the two sequences (Figure 4.2).  To determine if this putative 
phosphorylation site, Ser-289, was necessary for the activation by PKA, alanine was 
substituted by site-directed mutagenesis.  The resulting protein was expressed and 
purified from E. coli.  Addition of the purified mutant protein, SPF(S289A), to rat liver 
microsomes stimulated squalene monooxygenase activity by approximately 2-fold 
(results not shown) and to the same extent as wild-type SPF, demonstrating that the 
mutation did not impair basal activity (Figure 4.3).  However, the 2.3-fold activation 
of SPF by PKA was reduced by 60% in the S289A mutant, indicating that 
phosphorylation of this site contributes to the activation of SPF.  Activation of the 
protein by PKCδ was not affected by this mutation.   
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Figure 4.2 Amino acid sequence comparison between hSPF and rat SPF2 and 
the various possible sites of PKA phosphorylation on hSPF and rat SPF2. 
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Figure 4.3 Serine-289 is necessary for complete activation of SPF in vitro.  
Recombinant SPF(S289A) was incubated in the presence of PKA or PKCδ and 
ATP, and the ability of the preparations to stimulate microsomal squalene 
monooxygenase was determined.  Each value represents the mean ± S. E. of three 
experiments carried out in duplicate. 
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Ser-289 is Necessary for the Stimulation of Cholesterol Synthesis by SPF in 
Hepatoma Cells — To determine if phosphorylation of SPF at Ser-289 was 
necessary for the stimulation of cholesterol synthesis in SPF-transfected hepatoma 
cells, the S289A mutant was expressed in rat McARH7777 hepatoma cells and 
cholesterol synthesis was monitored by measuring the incorporation of 14C-acetate.  
Immunoblot analysis demonstrated that the S289A protein was expressed at a level 
approximately equivalent to that of wild-type SPF in these cells (Figure 4.1); 
however, the mutant protein was unable to stimulate cholesterol synthesis, in 
contrast to the nearly two-fold increase seen in cells expressing the wild-type SPF 
protein (Figure 4.4).  Thus, phosphorylation of SPF at Ser-289 appears necessary 
for maximal stimulation of squalene monooxygenase activity in vitro and cholesterol 
synthesis in cell culture.   
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Figure 4.4 Serine-289 is essential for the SPF-mediated increase in cholesterol 
synthesis in rat hepatoma cells.  The ability of SPF(S289A) to stimulate 
cholesterol synthesis in hepatoma cells was evaluated as described in 
“Experimental Procedures”.  Each value represents the mean ± S. E. of three 
experiments carried out in duplicate. 
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Dibutyryl-cAMP Stimulates Cholesterol Synthesis in Cells Expressing SPF — 
To determine if SPF activity in cultured cells was modulated by PKA, dibutyryl-
cAMP, a cell-permeable activator of PKA, was added to hepatoma cell cultures 
transfected with the control vector (pcDNA3.1) or wild-type SPF.  Dibutyryl-cAMP 
produced a 25% increase in cholesterol labeling when added along with 14C-
acetate, and a 52% increase when added 2 h prior to the addition 14C-acetate 
(Figure 4.5).  Dibutyryl-cAMP had no effect on cholesterol synthesis in cells that did 
not express SPF (note that hepatoma cells do not express an endogenous SPF – 
see Figure 4.1, lane 3).  These results indicate that SPF can be activated in 
response to cellular cAMP levels, and that in cells under these culture conditions (in 
the absence of dibutyryl-cAMP) SPF is not fully activated.   
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Figure 4.5 Cholesterol synthesis is stimulated by dibutyryl-cAMP in cells 
expressing SPF.  The ability of 0.2 mM dibutyryl-cAMP to stimulate cholesterol 
synthesis in rat hepatoma cells was determined at 0 and 2 h after addition of the 
cAMP analogue to the media, as described in “Experimental Procedures”.  Each 
value represents the mean ± S. E. of two experiments carried out in duplicate. 
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Inhibition of PKA Prevents the SPF-mediated Increase in Cholesterol 
Synthesis — The above results indicate that SPF must be phosphorylated on Ser-
289 to stimulate cholesterol synthesis.  To confirm a role for PKA in this activation, 
a cell-permeable PKA inhibitor peptide was added to SPF-transfected cultures and 
cholesterol synthesis was monitored.  The SPF-mediated increase in cholesterol 
synthesis was completely reversed by one hour after addition of the inhibitor, and 
the loss of SPF activity was maintained through 24 h (Figure 4.6).  The PKA 
inhibitor had no effect on cholesterol synthesis in cells that did not express SPF.  
These results suggest that phosphorylation of SPF by PKA is a dynamic process 
and that, in the absence of PKA activity, SPF is rapidly inactivated.   
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Figure 4.6 The stimulation of cholesterol synthesis by SPF is prevented by a 
PKA inhibitor.  The PKA inhibitor 14-22 amide (PKAi, 1 µM) was added to 
hepatoma cells expressing SPF or containing the control vector (pcDNA3.1) and 
cholesterol labeling was measured at 0, 1, 6, 12, and 24 h.  The -1 h time-point 
indicates cholesterol synthesis in the absence of the PKA inhibitor.  Each value 
represents the mean ± S. E. of two experiments carried out in duplicate. 
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Deletion of the Golgi Dynamics Domain Activates SPF in vitro but Prevents 
the Activation of SPF in Cell Culture — The carboxyl-terminal domain of SPF 
(amino acids 290 to 403) shows sequence similarity to proteins involved in Golgi 
function, including the p24 family, which are involved in coated vesicle transport 
from the endoplasmic reticulum to Golgi (Anantharaman and Aravind 2002).  This 
domain is not found in other lipid transfer proteins in the CRAL/TRIO family, 
including Sec14p and α-tocopherol transfer protein.  To determine if this domain 
was necessary for the SPF-mediated stimulation of squalene monooxygenase in 
vitro, SPF was truncated at amino acid 283 and the shortened protein expressed 
and purified from E. coli (Figure 4.1).  Although the shortened protein lacked Ser-
289, the required PKA phosphorylation site, its activity was 40% greater than that of 
full-length SPF that had been activated by incubation with PKA (Figure 4.7).  The 
truncated protein could not be further activated by PKA or PKCδ.  In contrast to this 
activation in vitro, deletion of the Golgi dynamics domain greatly reduced the ability 
of SPF to stimulate cholesterol synthesis in hepatoma cells (Figure 4.8).  SPF283 
was only 38% as effective as full-length SPF, and surprisingly, SPF292, which 
retains the PKA phosphorylation site (Ser-289) was completely inactive.  SPF383, 
from which only 20 amino acids were removed, retained the full ability to stimulate 
cholesterol synthesis although the amount of this protein expressed in these cells 
was much higher than WT SPF.  These results suggest that an interaction with 
Golgi or Golgi proteins is necessary for the stimulation of cholesterol synthesis in 
cells, but that, paradoxically, this domain hinders the stimulation of squalene 
monooxygenase in vitro.    The 3-dimensional view of the truncated proteins is 
shown in Figure 4.9. 
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Figure 4.7 Deletion of the Golgi dynamics domain increases the stimulation of 
microsomal squalene monooxygenase by SPF.  The stimulation of squalene 
monooxygenase activity in rat liver microsomes by SPF and SPF283, and their 
ability to be activated by PKA and PKC, was determined as described in 
“Experimental Procedures”.  Each value represents the mean ± S. E. of two or more 
experiments carried out in duplicate. 
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Figure 4.8 Deletion of the Golgi dynamics domain reduces the stimulation of 
cholesterol synthesis by SPF in cell culture.  The ability of SPF383, SPF292, 
and SPF283 to stimulate cholesterol synthesis in hepatoma cells was determined as 
described in “Experimental Procedures”.  Each value represents the ± S. E. of two 
or more experiments carried out in duplicate. 
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Figure 4.9 Various deletion constructs of hSPF. 
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Golgi are Required for the Stimulation of Cholesterol Synthesis by SPF — To 
determine if an interaction of SPF with Golgi was required for the stimulation of 
cholesterol synthesis in hepatoma cells, brefeldin A, which dissociates Golgi and 
disrupts Golgi function, was added to the cells 3-h prior to the addition of 14C-
acetate.  Brefeldin A completely prevented the stimulation of cholesterol synthesis 
by SPF (Figure 4.10).  The inhibition by brefeldin A could be reversed by replacing 
the media and allowing the cultures to recover for 2 h.  Brefeldin A had no effect on 
cholesterol synthesis in cells that did not express SPF. 
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Figure 4.10 Brefeldin A prevents the stimulation of cholesterol synthesis by 
SPF in cell culture.  Brefeldin A (BFA) was added to hepatoma cells 3 h prior to the 
addition of 14C-acetate and cholesterol labeling was determined.  For the washout 
experiment the media was replaced and 2 h later acetate incorporation into 
cholesterol was determined.  Each value represents the ± S. E. of two experiments 
performed in duplicate. 
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Discussion 
 
The ability of supernatant protein factor to stimulate cholesterol synthesis 
when expressed in hepatoma cells, first noted by Shibata et al. (Shibata, Arita et al. 
2001), has added a surprising new dimension to this long-known but poorly 
understood protein.  In the present studies we show that this stimulation is wholly 
dependent on phosphorylation by PKA at Ser-289, and that an apparent interaction 
with Golgi is further required.  The mechanism of this Golgi effect is unknown, but is 
evidenced by the loss of SPF activity in cells treated with brefeldin A, a 
disaggregator of Golgi, and the loss of SPF activity upon deletion of the carboxyl-
terminal Golgi dynamics domain thought to be involved in the interaction of Golgi-
associated proteins.  Paradoxically, the deletion of this domain significantly 
enhances the ability of SPF to stimulate squalene epoxidation in microsomal 
preparations, the original activity ascribed to SPF.  This finding appears to 
dissociate the cholesterolgenic effect of SPF in whole cells from the stimulation of 
this cholesterolgenic enzyme in vitro, and with both effects the mechanism of the 
stimulation by SPF remains unknown.   
In the present studies cholesterol synthesis was estimated by radiolabel 
incorporation from 14C-acetate added to the media.  Although this is a widely used 
and generally reliable method for determining relative rates of cholesterol synthesis 
(Dietschy and Spady 1984), the “pool size” of unlabeled acetate in the cell will affect 
radiolabel incorporation, and it is formally possible that SPF might increase label 
incorporation by decreasing the amount of unlabeled acetate available for 
incorporation, or by enhancing the uptake or activation of radiolabeled acetate in the 
cell.  We measured the accumulation of 14C after 1 h of incubation with 14C-acetate 
and found no effect of SPF expression on the total radioactivity in cells, indicating 
that SPF does not affect the uptake of acetate (results not presented).  Our studies 
with a PKA activator (dibutyryl-cAMP) and inhibitor (14-22 amide), as well as with 
brefeldin A similarly argue against an effect of SPF on the unlabeled acetate pool; 
the effects of these compounds on cholesterol synthesis were seen almost 
immediately, within the 3-h time-period of the assay, and in particular the brefeldin A 
washout experiment rapidly restored SPF activity (Fig. 9).  It is difficult to envision 
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how this effect on Golgi might mediate a change in acetate levels in the cell through 
SPF; rather, they are consistent with the hypothesis that SPF acts to rapidly and 
directly modulate cholesterol synthesis in response to cellular and extracellular 
signals, including cAMP (Singh, Mokashi et al. 2003).   
The ability of SPF to increase cholesterol synthesis in whole cells, coupled 
with its ability to stimulate squalene monooxygenase activity in microsomes, implies 
that SPF increases cholesterol synthesis by stimulating squalene monooxygenase 
activity in cells.  However, squalene monooxygenase is not generally regarded as 
the rate-limiting step in cholesterol synthesis, a distinction reserved for HMG-CoA 
reductase.  Thus, increasing squalene monooxygenase activity would not be 
expected to increase cholesterol synthesis, raising the possibility that SPF promotes 
cholesterolgenesis by additional mechanisms.  Our finding that removal of the Golgi 
dynamics domain from SPF impairs its ability to increase cholesterol synthesis in 
cell culture while significantly increasing its ability to stimulate squalene 
monooxygenase activity in microsomes is consistent with this suggestion.  This 
paradoxical result argues that the increase in cholesterol synthesis is not mediated 
through an increase in squalene monooxygenase activity, but rather involves an 
interaction of SPF with Golgi or Golgi-associated proteins.  It should be noted that 
Shibata et al. (Shibata, Arita et al. 2001) reported that SPF expression in hepatoma 
cells led to an increase in squalene levels (as well as lanosterol and cholesterol), an 
effect that also would not be expected if SPF acted only on squalene 
monooxygenase.   
The dependency of SPF on intact Golgi and phosphorylation bears strong 
similarity to the regulation of oxysterol binding proteins.  This family of proteins has 
been shown to associate with Golgi in response to cholesterol depletion and to be 
phosphorylated by an unidentified Golgi-associated protein kinase (Ridgway, 
Badiani et al. 1998; Storey, Byers et al. 1998).  Treatment of cells with brefeldin A 
leads to dephosphorylation (Ridgway, Badiani et al. 1998), as does severe 
cholesterol depletion (Mohammadi, Perry et al. 2001).  Notably, overexpression of 
oxysterol binding protein in mouse hepatoma cells increased the expression of 
several cholesterolgenic enzymes, including HMG-CoA reductase, and increased 
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cholesterol synthesis by 80% (Lagace, Byers et al. 1997).  The present studies 
suggest a new and parallel kinase-dependent regulatory pathway for the rapid 
modulation of cholesterol synthesis in which cAMP and PKA activate SPF to directly 
stimulate cholesterol synthesis.   
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CHAPTER 5 
 
SUPERNATANT PROTEIN FACTOR STIMULATES HMG-COA REDUCTASE IN 
CELL CULTURE AND IN VITRO  
Introduction 
 
Cholesterol synthesis is a highly regulated pathway subject to transcriptional, 
translational, and post-translational control.  Although all cholesterolgenic enzymes 
appear to be subject to some level of coordinate regulation (Sakakura, Shimano et 
al. 2001).  HMG-CoA reductase is thought to be the rate-controlling step in the 
overall pathway and thus is subject to both long-term and short-term regulatory 
mechanisms (Russell 1992; Ness and Chambers 2000).  Short-term regulatory 
mechanisms include inactivation by phosphorylation (Ingebritsen 1983), changes in 
the rate of degradation in response to hormones, tocotrienols, sterols, and sterol 
intermediates (Parker, Pearce et al. 1993; Ness and Chambers 2000; Sever, Song 
et al. 2003) and membrane fluidity-mediated effects on activity (Davis and 
Poznansky 1987).  The mechanisms by which membrane fluidity is modulated in 
cells, and how this alters HMG-CoA reductase activity, remain to be defined.   
 
Shibata et al. (Shibata, Arita et al. 2001) recently reported that SPF, when 
transfected into hepatoma cells that do not express endogenous SPF, increases 
cholesterol synthesis by nearly three-fold. Our studies confirm this observation 
(Chapter 4).  Because squalene monooxygenase is not considered to be rate-
limiting in cholesterol synthesis, these findings suggest that SPF may affect 
additional cholesterolgenic enzymes, perhaps in a general fashion by altering the 
lipid composition of the associated endoplasmic reticulum.  The present studies 
were undertaken to determine where SPF acts in the cholesterolgenic pathway to 
enhance cholesterol synthesis.  The various inhibitors used in this study are shown 
in Fig 5.1.  The results reveal that SPF stimulates both squalene monooxygenase 
and HMG-CoA reductase in vitro as well as in cell culture. 
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Figure 5.1 Various inhibitors used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Squalene
monooxygenase
Oxidosqualene
cyclase
Squalene
2,3-Oxidosqualene
Lanosterol
Acetate
Mevalonate
Farnesyl pyrophosphate
Cholesterol
Lovastatin
Terbinafine
AMO 1618
HMG-CoA
reductase
6 steps
HMG-CoA
2 steps
19 steps
Squalene synthase
 57
Experimental Methods 
 
Hepatoma Cell Culture and Transfection — The human SPF cDNA was cloned 
into the mammalian expression vector pcDNA3.1 by polymerase chain amplification 
and plasmid DNA was prepared from E. coli transformants with the Wizard 
Midipreps DNA Purification System (Promega).  McARH7777 rat hepatoma cells 
were plated at a density of 5 × 104 cells per square centimeter into 6-well cell-
culture plates in 2 ml of Dulbecco’s Modified Eagle’s Medium with 10% fetal bovine 
serum and 1% penicillin/streptomycin/glutamine solution (day 1).  After 24 h the 
purified plasmid DNA was transfected into the cells at 1 µg/well with the use of 
LipofectAMINE-Plus transfection reagent (Invitrogen).  Cell viability after 
transfection, as assessed by trypan blue exclusion on day 4, was approximately 
80%; transfection efficiency was approximately 70-80%, determined by 
cotransfection of a β-galactosidase expression plasmid. 
Determination of Cholesterol Synthesis in Hepatoma Cells — Cholesterol 
synthesis was determined on day 4 in vector-transfected cells (pcDNA3.1) and cells 
containing the SPF expression construct.  14C-Acetate (Amersham Biosciences, 60 
mCi/mmol) or 14C-mevalonate (Amersham Biosciences, 60mCi/mmol) was added (1 
µCi/well) and the cells were incubated at 37 °C for 3 h.  Mevinolin (1 µM, Sigma 
Chemical Co.) was included in incubations with 14C-mevalonate to block HMG-CoA 
reductase, and lipid-replete serum was used in all studies.  The media was 
removed, the cells were washed twice with 2 ml of 1% phosphate-buffered saline 
solution, pH 7.4, harvested by scraping, resuspended in 20 mM Tris-EDTA buffer, 
pH 7.4, containing 0.1% Triton X-100, and lysed by sonication three times for 5 s 
with a Sonic Dismembrator (Fisher Scientific) at medium setting.  Lipids were 
extracted without saponification (to allow quantitation of cholesterol-esters) with a 
mixture of chloroform/methanol (2:1), subjected to centrifugal evaporation, 
resuspended in 50 µl of the same and resolved by silica thin-layer chromatography 
(Whatman, Inc.) in petroleum ether/ethyl ether/acetic acid (60:40:1).  Radiolabeled 
cholesterol and cholesterol-esters were visualized and quantified by electronic 
autoradiography (Packard Instant Imager) and authenticated by comparison to 
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standards visualized by iodine-vapor stain, and cholesterol was also authenticated 
by gas-chromatographic/mass spectrometry of the eluted sample.  Cholesterol 
synthesis was normalized to that of cells transfected with the vector (pcDNA3.1), 
setting synthesis in these cells at 100%. 
For the pulse-chase experiment, cells were incubated with 14C-acetate for 3 
hr, after which the media was decanted, the cells were washed, and fresh media 
added.  Radiolabeled cholesterol and cholesterol-esters were quantified in the cells 
and media at various times thereafter; the media was clarified by low-speed 
centrifugation to remove cells and cell debris, and cholesterol was quantified in both 
the supernatant and cell pellet as described above. 
Determination of Squalene Synthesis in Hepatoma Cells — Squalene 
synthesis from 14C-acetate or 14C-mevalonate was measured in vector-transfected 
cells (pcDNA3.1) and cells containing the SPF expression construct, utilizing 60 µM 
terbinafine (TCI America, Inc.) to block squalene monooxygenase, the subsequent 
enzyme in the pathway.  Mevinolin (1 µM) was included in incubations with 14C-
mevalonate.  Radiolabeled substrate was added at 1 µCi/well and the cells were 
incubated at 37 °C for 3 h.  The media was removed, the cells washed twice with 
1% phosphate-buffered saline solution, pH 7.4, harvested by scraping, resuspended 
in 20 mM Tris-EDTA buffer, pH 7.4, and lysed by sonication three times for 5 s.  
Lipids were saponified in 0.5 ml of methanolic potassium hydroxide at 80 °C for 1 h.  
Neutral lipids were extracted with 5 ml of petroleum ether, subjected to centrifugal 
evaporation, resuspended in 50 µl of the same and resolved by silica thin-layer 
chromatography in 5% ethyl acetate in hexane.  Radiolabeled squalene was 
quantified by electronic autoradiography and authenticated by comparison to a 
squalene standard visualized by iodine-vapor stain. 
Determination of 2,3-Oxidosqualene Synthesis in Hepatoma Cells — 2,3-
Oxidosqualene synthesis from 14C-acetate or 14C-mevalonate was measured in 
vector-transfected cells (pcDNA3.1) and cells containing the SPF expression 
construct in the presence of 1.5 mM AMO 1618 (Calbiochem), an inhibitor of 
oxidosqualene cyclase, the subsequent enzyme in the pathway.  Mevinolin (1 µM) 
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was included in incubations with 14C-mevalonate.  Radiolabeled substrate was 
added at 1 µCi/well and cells were incubated at 37 °C for 3 h, after which the media 
was removed, the cells were washed twice with 1% phosphate-buffered saline 
solution, pH 7.4, harvested by scraping, resuspended in 20 mM Tris-EDTA buffer, 
pH 7.4, containing 0.1 % Triton X-100 and lysed by sonication three times for 5 s.  
Lipids were saponified in 0.5 ml of methanolic potassium hydroxide at 80 °C for 1 h.  
The neutral lipids were extracted with 5 ml of petroleum ether, subjected to 
centrifugal evaporation, resuspended in 50 µl of the same and resolved by silica 
thin-layer chromatography in 5% ethyl acetate in hexane.  Radiolabeled 2,3-
oxidosqualene was quantified by electronic autoradiography.   
Determination of HMG-CoA Reductase Activity in vitro — The microsomal 
fraction (100,000 x g pellet, resuspended at ~15 mg of protein/ml in 20 mM Tris 
buffer, pH 7.4) and the cytosolic fraction (100,000 X g supernatant, diluted to ~15 
mg of protein/ml) were prepared by standard procedures from the livers of untreated 
male Harlan Sprague-Dawley rats (~200 g).  HMG-CoA reductase activity was 
determined as described by Brown and Goldstein (Brown, Dana et al. 1974), as 
follows:  Microsomal protein (100 µg) was incubated at 37 °C for 3 h in a final 
volume of 200 µl of 0.1 M potassium phosphate buffer, pH 7.5, containing 20 mM 
glucose 6-phosphate, 2.5 mM NADP+, 1 unit of glucose 6-phosphate 
dehydrogenase (Sigma), 5 mM dithiothreitol, and 0.2 µCi 14C-HMG-CoA (55 
mCi/mmol, American Radiolabeled Chemicals, Inc.).  Purified recombinant human 
SPF or rat liver cytosol were added as indicated.  The reaction was stopped by 
addition of 20 µl of 6 M HCl, incubated at 37 °C for 30 min to convert the product to 
14C-mevalonolactone, and extracted twice with 5 ml of diethyl ether/ethyl acetate.  
The ether extracts were evaporated to dryness by centrifugal evaporation and the 
lipids separated by thin layer chromatography in benzene/acetone (1:1, v/v).  
14C-Mevalonolactone was authenticated by comparison to a mevalonolactone 
standard visualized by iodine-vapor stain and quantified by electronic 
autoradiography.  Microsomal squalene monooxygenase activity was determined as 
described previously (Singh, Mokashi et al. 2003).   
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Activation of SPF by Protein Kinase A and Cδ — Protein kinase A and Cδ 
incubations with SPF were carried out according to the manufacturer’s instructions 
with mouse recombinant PKA catalytic unit Cα, 5 units (Calbiochem) or 0.25 units of 
human recombinant PKC isozyme δ (Calbiochem), 5 µg of SPF, and 3 mM ATP for 
30 min at 30 °C.  Unbound nucleotide was removed by centrifugal filtration 
(Microcon concentrator, 30 kD cutoff) and SPF protein was resuspended in 20 mM 
Tris buffer, pH 7.4, and added to microsomal assays as described above.   
 
Immunoblot Analysis of HMG-CoA Reductase and Squalene Monooxygenase 
Expression —  Hepatoma cells were harvested 48 h after transfection, lysed by 
sonication as described above, and the lysate cleared by centrifugation at 12,000 x 
g for 30 min at 4 °C.  The cleared lysate was fractionated by sodium dodecyl 
sulfate–polyacrylamide gel electrophoresis on 8.5% gels, electrophoretically 
transferred to nitrocellulose membranes, and probed with polyclonal antibody to 
human HMG-CoA reductase (Upstate USA, Inc.) or human squalene monooxygenase 
(prepared by Animal Pharm Services, Inc).  The immunoblots were developed with a 
secondary antibody conjugated to alkaline phosphatase.   
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Results 
 
SPF increases cholesterol synthesis — Shibata et al. (Shibata, Arita et al. 
2001)reported that expression of SPF in hepatoma cells increases cholesterol 
synthesis by 2-3-fold, but did not define the mechanism or parameters of this 
stimulation.  To confirm and explore this unexpected finding, we measured 
cholesterol synthesis from 14C-acetate in McARH7777 rat hepatoma cells at various 
times after transfection of an SPF-expression plasmid.  As shown in Fig. 5.2A, SPF 
expression increased cholesterol synthesis by approximately 75% and maintained 
elevated rates for at least 24 hr (note that in these experiments time 0 represents 48 
h after transfection).  Cholesterol synthesis returned to normal levels by 48 h 
despite the continued expression of SPF (data not shown), indicating that the cells 
countered the SPF-mediated increase in cholesterol by down-regulating synthesis 
at one or more points in the pathway.  To determine how the newly synthesized 
cholesterol was processed in the cell, a pulse-chase experiment was carried out in 
which cells were incubated with 14C-acetate for 3 h, starting at time 0, after which 
the media was replaced and radiolabeled cholesterol and cholesterol-esters were 
quantified at various times thereafter in the cells and media.  As shown in Fig. 5.2B, 
cholesterol labeling in SPF-transfected cells was doubled at 3 h, relative to vector-
transfected cells (Fig. 5.2C), and returned to control levels by 24 h.  Cholesterol-
esters in SPF-transfected cells increased slightly at 6 h and then declined in 
conjunction with cholesterol labeling, whereas esters increased slightly over time in 
vector-transfected cells.  Cholesterol in the clarified media from SPF-transfected 
cells increased over the period of the experiment, such that the “excess” cholesterol 
synthesized in the first 3-h could be accounted for in the media by 24 h.  Cholesterol 
in the media of vector-transfected cells increased only slightly over the period of the 
experiment.  These results indicate that SPF stimulates cholesterol synthesis in 
hepatoma cells for up to 72 h after transfection and that this newly synthesized 
cholesterol is largely secreted from the cells into the media.   
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Fig. 5.2 SPF expression increases cholesterol synthesis and cholesterol 
secretion into the media.  A, 14C-Acetate was added to SPF-transfected or vector-
transfected cells at the times indicated and radiolabeled cholesterol was quantified 
after 3 h.  Each value represents the mean ± S. E. of two experiments carried out in 
duplicate.  B, SPF-transfected cells or C, vector-transfected cells were incubated 
with 14C-acetate for 3 h, after which the media was replaced and radiolabeled 
cholesterol and cholesterol-esters were quantified at the times indicated.  The open 
symbols indicate labeled cholesterol in the clarified media.  Each value represents 
the average and standard deviation of duplicate determinations.   
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SPF increases mevalonate synthesis — Preliminary studies revealed that SPF 
expression increased cholesterol synthesis by nearly two-fold when measured by 
14C-acetate incorporation, but that this effect was blunted when 14C-mevalonate was 
substituted for 14C-acetate.  These results suggested that SPF was acting at or prior 
to the synthesis of mevalonate.  To test this hypothesis, squalene synthesis was 
measured in these cells in the presence of terbinafine, a squalene monooxygenase 
inhibitor, to prevent squalene from being further metabolized.  Squalene synthesis 
from 14C-acetate was increased by 50% in cells transfected with the SPF expression 
vector when compared to vector-transfected control cells, but was unchanged from 
control values when measured with 14C-mevalonate (Fig. 5.3).  These results 
support the contention that SPF stimulates mevalonate synthesis.  Because 
mevinolin, a potent inhibitor of HMG-CoA reductase, was included in the assays 
utilizing 14C-mevalonate, these results further indicate that SPF does not affect 
enzymes after HMG-CoA reductase and prior to squalene monooxygenase, 
including squalene synthase.   
 
SPF increases squalene monooxygenase activity in hepatoma cells — As 
shown in Fig. 5.4, cholesterol synthesis was increased in SPF-expressing cells by 
78% when measured with 14C-acetate; however, cholesterol synthesis was 
increased by 42% when measured with 14C-mevalonate in the presence of 
mevinolin, indicating that SPF was also acting downstream of HMG-CoA reductase.  
Because SPF is well established to stimulate squalene monooxygenase in vitro, we 
measured the synthesis 2,3-oxidosqualene (the product of squalene 
monooxygenase) in the presence of AMO 1618, an inhibitor of oxidosqualene 
cyclase, to prevent 2,3-oxidosqualene from being converted to lanosterol.  
Oxidosqualene synthesis was increased by 50% when measured with 14C-acetate 
and by 32% when measured with 14C-mevalonate in the presence of mevinolin 
(Fig.5.3), indicating that SPF expression increases squalene monooxygenase 
activity in hepatoma cells.  Immunoblot analysis with antibody to squalene 
monooxygenase demonstrated that squalene monooxygenase expression was not 
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increased in cells that express SPF, indicating that the effect of SPF is on enzyme 
activity (see Fig 5.4)   
SPF also stimulates oxidosqualene cyclase in vitro (Srikantaiah, Hansbury et 
al. 1976; Caras and Bloch 1979), but it was not possible to test the effect of SPF 
expression on this enzyme in cell culture, as hepatoma cells do not efficiently take 
up post-squalene intermediates (unpublished data).  SPF was reported to not affect 
cholesterolgenic enzymes downstream of lanosterol (Caras and Bloch 1979).   
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Fig. 5.3 Effect of SPF expression on squalene, 2,3-oxidosqualene, and 
cholesterol synthesis from 14C-acetate and 14C-mevalonate in hepatoma cells.  
Product formation is reported as a percentage of the amount formed in cells 
transfected with the pcDNA3.1 vector, and determined as described in 
“Experimental Procedures”.  Each value represents the mean ± S.E. of two to four 
experiments carried out in duplicate. 
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Fig. 5.4 SPF expression does not alter HMG-CoA reductase or squalene 
monooxygenase expression.  Cleared lysates prepared from vector-transfected or 
SPF-transfected cells were fractionated by SDS-polyacrylamide gel electrophoresis 
and transferred to nitrocellulose for immunodetection with polyclonal antibodies to 
HMG-CoA reductase (HMGR) or squalene monooxygenase (SM).   
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SPF stimulates HMG-CoA reductase in vitro — The increase in mevalonate 
synthesis in cells expressing SPF suggests that SPF increases either the 
expression or activity of one or more enzymes upstream of mevalonate.  
Immunoblot analysis with antibody to HMG-CoA reductase demonstrated that the 
expression of this enzyme was not increased in cells that express SPF (Fig. 5.4).  
The expression of HMG-CoA synthase and β-ketothiolase, the enzymes that 
precede HMG-CoA reductase in the pathway, was not examined.  However, 
because HMG-CoA reductase is believed to be the rate-limiting enzyme in 
cholesterol synthesis, these results suggest that SPF directly stimulates the activity 
of this enzyme.  To test this hypothesis, microsomes were prepared from rat liver 
and the effect of purified recombinant SPF on mevalonate synthesis from 14C-HMG-
CoA was determined.  As shown in Fig. 5.5, addition of SPF increased HMG-CoA 
reductase activity by up to 60%, with maximum stimulation occurring at 0.8 µg of 
SPF per assay.  The SPF-activation curve for HMG-CoA reductase paralleled that 
for squalene monooxygenase, with greater amounts of SPF proving inhibitory, as 
has been seen previously with squalene monooxygenase (Singh, Mokashi et al. 
2003; Mokashi, Singh et al. 2004).  Rat liver cytosol also stimulated HMG-CoA 
reductase activity to a similar extent, but the stimulatory range was narrow, and 
higher concentrations were strongly inhibitory.  The reason for the inhibition at 
higher concentrations of SPF and cytosol has not been determined.    
Our recent studies have revealed that SPF is activated by protein kinases A 
and C in vitro, indicating that phosphorylation may play a role in the regulation of 
SPF activity (Singh, Mokashi et al. 2003).  To determine if activation of SPF could 
be seen with HMG-CoA reductase, SPF was incubated with PKA or PKCδ and ATP 
prior to addition to microsomes.  As shown in Fig. 5.6, the stimulation of HMG-CoA 
reductase afforded by SPF was nearly doubled by incubation with PKA, with a 
lesser increase with PKCδ.  These results closely resemble those seen with 
squalene monooxygenase previously (Singh, Mokashi et al. 2003) and argue that 
SPF stimulates HMG-CoA reductase and squalene monooxygenase by identical 
mechanisms.   
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Fig. 5.5 SPF and cytosol stimulate HMG-CoA reductase in vitro.  HMG-CoA 
reductase (HMGR) and squalene monooxygenase (SM) activity were determined as 
described in “Experimental Procedures” in the presence of different amounts of SPF 
or rat liver cytosol, as indicated.  Each value represents the mean ± S.E. of three 
experiments carried out in duplicate.   
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Fig. 5.6 Activation of SPF by PKA and PKCδ increases its ability to stimulate 
HMG-CoA reductase in vitro.  SPF or SPF activated by incubation with PKA or 
PKCδ and ATP was added to rat liver microsomal preparations and HMG-CoA 
reductase activity was determined as described in “Experimental Procedures”.  
Each value represents the mean ± S.E. of two or three experiments carried out in 
duplicate. 
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Discussion 
 
 
SPF has long been known to stimulate squalene monooxygenase and 
oxidosqualene cyclase in microsomal preparations (Tai and Bloch 1972; Saat and 
Bloch 1976; Caras and Bloch 1979).  In the present studies SPF is shown to 
stimulate squalene monooxygenase in cultured hepatoma cells, indicating that the 
effect is not restricted to microsomal preparations; moreover, SPF also increased 
HMG-CoA reductase activity, possibly in cell culture and when added to rat liver 
microsomes.  These results suggest that SPF is able to modulate cholesterol 
synthesis at two key regulatory points in the cholesterolgenic pathway, presumably 
by the same mechanism.  Cholesterol synthesis was elevated by 48 h after 
transfection and continued for another 24 h, after which synthesis returned to 
control levels despite the continued presence of SPF.  This result suggests that the 
cells compensate for the presence of SPF by downregulating cholesterol synthesis 
at other points in the pathway, or by inactivating SPF by dephosphorylation.  
Current studies are directed at identifying this compensatory mechanism.  The 
newly synthesized cholesterol is rapidly processed in the cell and is fully secreted 
into the media as free cholesterol by 24 h.  The stimulation afforded by SPF cannot 
be generalized to all cholesterolgenic enzymes, as the conversion of mevalonate to 
squalene is unaffected by SPF; this also excludes a general effect on membrane-
bound enzymes, as squalene synthase is unaffected by SPF.  Although 
oxidosqualene cyclase (lanosterol synthase) is also stimulated by SPF when 
assayed in microsomal preparations (Saat and Bloch 1976; Caras and Bloch 1979), 
we were not able to determine if SPF stimulates enzymes downstream of squalene 
monooxygenase, including oxidosqualene cyclase, in cultured cells, as hepatocytes 
do not readily take up post-squalene and sterol intermediates.  Caras and Bloch 
(Caras and Bloch 1979) reported that SPF did not affect the subsequent conversion 
of lanosterol to cholesterol.   
  Although HMG-CoA reductase enzyme levels are modulated by sterols and 
non-sterol cholesterol intermediates at both the transcriptional and post-
transcriptional level (Ness and Chambers 2000), SPF did not affect HMG-CoA 
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reductase or squalene monooxygenase expression, and the stimulatory effect in 
cells could be fully replicated by adding SPF to microsomal preparations.  This 
stimulation could also be observed with rat liver cytosol, although, in contrast to 
squalene monooxygenase (Singh, Mokashi et al. 2003), the stimulation of HMG-
CoA reductase by cytosol was evidenced over a narrow range, with higher 
concentrations proving to be strongly inhibitory.  Although Lehrer et al. (Lehrer, 
Panini et al. 1981) noted that cytosol stimulated HMG-CoA reductase (see 
discussion below), the modest stimulation produced by cytosol (less than two-fold) 
and the narrow effective range may explain why this effect was not explored in 
earlier studies.  Notably, the stimulation of HMG-CoA reductase and squalene 
monooxygenase by SPF can be increased several-fold by phosphorylation, with 
PKA being most effective.  This suggests that SPF may serve as a short-term, rapid 
modulator of cholesterol synthesis in cells in response to diverse hormonal and 
environmental signals.   
Although SPF has been proposed as a carrier protein for squalene and has 
been shown to facilitate the movement of squalene between membranes in vitro 
(Friedlander, Caras et al. 1980; Kojima, Friedlander et al. 1981; Fuks-Holmberg and 
Bloch 1983; Shibata, Arita et al. 2001), squalene transfer would not appear to be 
relevant to the stimulation of HMG-CoA reductase, raising the possibility that SPF 
acts by some other mechanism.  SPF has a four-fold higher affinity for 
phosphatidylinositol than for squalene (Panagabko, Morley et al. 2003), suggesting 
that SPF may be a phosphatidylinositol transfer protein, analogous to Sec14p in 
yeast.  Indeed, SPF and Sec14p are both members of the CRAL/TRIO family of 
lipid-binding proteins, and share approximately 30% sequence identity.  SPF binds 
tightly to anionic, but not cationic, phospholipid vesicles (Caras, Friedlander et al. 
1980), and anionic phospholipids (phosphatidylinositol and phosphatidylserine) 
increase squalene monooxygenase activity by 8-fold alone but 40-fold when SPF is 
included (Tai and Bloch 1972).  These findings are consistent with a role for SPF in 
anionic phospholipid transfer; however, anionic phospholipids have not been shown 
to stimulate HMG-CoA reductase (Berde, Heller et al. 1977).  And, although 
numerous early reports suggested that membrane fluidity, as mediated by 
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cholesterol content, modulates HMG-CoA reductase activity, many of these early 
findings can now be reinterpreted in light of our current understanding of how 
sterols promote Insig-mediated ubiquitination and degradation of HMG-CoA 
reductase (Sever, Song et al. 2003; Sever, Yang et al. 2003).  Nonetheless, Lehrer 
et al. (Lehrer, Panini et al. 1981), in studies on the inhibition of HMG-CoA reductase 
by lipids, reported that rat liver cytosol reversed oleic acid and oleoyl-CoA inhibition 
and stimulated HMG-CoA reductase activity in microsomes by up to 33%.  Although 
this stimulation was attributed to the presence of phosphatase in the cytosol which 
could reactivate phosphorylation-inactivated enzyme (Hardie 1992; Omkumar, 
Darnay et al. 1994), the possibility was considered that this stimulation was 
mediated by a cytosolic lipid-binding protein.  The present findings that SPF 
stimulates HMG-CoA reductase in microsomes are remarkably consistent with this 
early observation, and suggest a new means by which cholesterol synthesis is 
regulated in the cell.   
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CHAPTER 6 
 
CONCLUSIONS 
 
Regulation of HMG-CoA Reductase 
 
The endoplasmic reticulum bound-enzyme, 3-hydroxy-3-methylglutaryl-coenzyme A 
(HMG-CoA) reductase, is generally considered as catalyzing the rate limiting step in 
cholesterol biosynthesis (Bucher, Overath et al. 1960). 
 HMG-CoA reductase is regulated by several mechanisms.  Feedback regulation 
of hepatic cholesterol synthesis was recognized nearly 50 years ago (Gould 1950; 
Gould 1951; Gould 1953).  The activity of HMG-CoA reductase can be altered in 
response to changes in dietary cholesterol (Brown, Dana et al. 1974).  In addition to 
dietary factors, HMG-CoA reductase activity can be modified at different levels; these 
include the transcription, translation, protein turnover and regulation of catalytic activity 
by phosphorylation/dephosphorylation.  The possibility that HMG-CoA reductase could 
be regulated by phosphorylation/dephosphorylation was introduced by Beg et al. (Beg, 
Allmann et al. 1973).  Subsequent studies revealed that HMG-CoA reductase could be 
phosphorylated and inactivated by an AMP-activated protein kinase (Parker, Miller et al. 
1989; Clarke and Hardie 1990; Hardie 1992).  The site of phosphorylation was identified 
as serine 871 (Clarke and Hardie 1990).  Recent studies have revealed that one 
important form of feedback regulation of HMG-CoA reductase involves the control of the 
rate of protein degradation (Yang, Espenshade et al. 2002). 
A study done by Asslan et al. in 1998 demonstrated that HMG-CoA reductase 
activity could be modified by herbimycin, a non-specific tyrosine kinase inhibitor (Asslan, 
Pradines et al. 1998).  This decrease in HMG-CoA reductase activity by tyrosine kinase 
inhibitor was shown to be at the level of mRNA.  Later studies also demonstrated that 
HMG-CoA reductase mRNA levels could be increased by cAMP, thereby increasing the 
activity of HMG-CoA reductase (Golos and Strauss 1988).   
The idea that HMG-CoA reductase activity could be modified by changes in 
membrane fluidity was introduced four decades ago.  Berde et al. in 1977 demonstrated 
that HMG-CoA reductase activity was stimulated by phospholipids (Berde, Heller et al. 
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1977).  They showed that microsomal lipids including phosphatidylcholine, 
phosphatidylethanolamine and phosphatidylserine increased HMG-CoA reductase 
activity in vitro. A subsequent study done by Heusden et al. in 1984 demonstrated that a 
non-specific lipid transfer protein, which transfers cholesterol and natural phospholipids 
between membranes, could not change HMG-CoA reductase activity (van Heusden and 
Wirtz 1984).  Contradictory to this study, the study done by Davis et al, in 1987 
demonstrated that addition of rigid or fluid phospholipids to microsomal membranes 
modulated HMG-CoA reductase activity in vitro (Davis and Poznansky 1987).  This data 
supports the idea that HMG-CoA reductase and consequently cholesterol biosynthesis 
could be regulated by the fluidity or the composition of the endoplasmic reticulum 
membranes.  However, the nexus between membrane fluidity and HMG-CoA reductase 
remains elusive. 
 
The observation that SPF stimulates HMG-CoA reductase both in vitro and in cell 
culture is very surprising.  Tormanen et al. in 1977 observed that when rat liver 
microsomes were treated with cytosol from the same animals, the activity of HMG-CoA 
reductase in vitro was reduced (Tormanen, Srikantaiah et al. 1977).  In contrast Lehrer 
et al, in 1981 had demonstrated that addition of crude rat liver cytosol to microsomes 
increased the HMG-CoA reductase activity (Lehrer, Panini et al. 1981).  In my studies 
the amount of cytosol and also the amount of recombinant SPF protein added to these 
assays is paramount.  Excessive amounts of both lead to a decrease in activity, and the 
exact reason is yet unknown.   
 
The present studies demonstrate an unexpected but exciting finding: Human 
supernatant protein factor, which was known to stimulate the reaction catalyzed by 
squalene monooxygenase, also acts on the key rate-limiting enzyme in cholesterol 
synthesis, HMG-CoA reductase (HMGR).  The exact mechanism by which SPF effects 
the stimulation is yet unknown, but two possible schemes can be proposed. 
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Possible Schemes of Activation 
 
SCHEME1:  SPF is known to bind to phospholipids such as phosphatidylserine, 
phosphatidylinositol and phosphatidylglycerol.  It is possible that SPF transfers these 
ligands on to endoplasmic reticulum membranes where HMG-CoA reductase is present, 
and inserts these ligands into the membrane, thereby altering the properties of the 
membrane and increasing the rate of the reaction catalyzed by HMG-CoA reductase.  
Evidence comes from the studies Berde et al. (Berde, Heller et al. 1977) who 
demonstrated that phospholipids activate the HMG-CoA reductase reaction. In addition 
Davis and Poznasky in 1987 demonstrated that HMG-CoA reductase activity is 
sensitive to changes in the phospholipid composition of the membrane (Davis and 
Poznansky 1987).  The same authors also showed that when the membrane fluidity was 
increased HMG-CoA reductase activity was reduced.  SPF could be transferring its lipid 
ligands to the membrane and consequently decreasing the fluidity of the membrane and 
stabilizing it (Fig 6.1A). 
 
SCHEME 2:  SPF protein contains a CRAL-TRIO domain believed to be involved 
in lipid-binding.  TRIO proteins are multi-domain proteins which have been determined 
to play an important role as a guanine exchange factor and in neuronal growth 
(Bateman and Van Vactor 2001).  Rho GTPase activating protein (RhoGAP) has been 
found to interact with HMG-CoA reductase in a yeast two hybrid system (Nagaraja and 
Kandpal 2004). In addition SPF possess a GOLD (Golgi dynamics) domain, and it has 
been shown that the GOLD-domain proteins can interact with other proteins and 
function as double headed adapters and interact with specific protein and/or 
membranes (Anantharaman and Aravind 2002).  It is possible that SPF may actually be 
interacting with HMG-CoA reductase in ways unknown and increasing the rate of the 
reaction (Fig 6.1B). 
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Figure 6.1 Possible mechanisms of the SPF-mediated activation of HMG-CoA 
reductase.  
 
 
A: SPF transfers its putative ligand to the membrane and thereby increases membrane 
stability, causing an increase in HMG-CoA reductase activity.   
SP
F
STABLE MEMBRANE
SP
F
UNSTABLE MEMBRANE
H
M
G
CR
H
M
G
CR
 
 
 
 
 
 
 
 
 
B:  SPF directly interacts with HMG-Co A reductase at the membrane, thereby 
increasing HMG-CoA reductase activity. 
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Protein Kinase A and SPF Regulation 
 
 Protein kinases have been linked to the regulation of cholesterol synthesis and 
homeostasis, and the best characterized action is that of the down-regulation of HMG-
CoA reductase activity by AMP-activated protein kinase (Hardie 1992) and by PKC 
(Mehta, Radominska-Pandya et al. 2002).  Protein kinase A (PKA) is very effective in 
activating recombinant SPF in vitro and also the SPF-mediated stimulation of 
cholesterol synthesis in cell culture.  PKA has not been earlier implicated in the 
regulation of cholesterol synthesis, although it plays an important role in the activation of 
cholesterol transport to the mitochondria for steroidogenesis (Arakane, King et al. 
1997).  PKA has also been implicated in the up-regulation of the low density lipoprotein 
receptor (Sekar and Veldhuis 2001).  PKA is a cAMP-dependent kinase and thus can 
be activated by many of the adenylate-cyclase dependent signaling pathways available 
to the cell.   The study presented above demonstrates that SPF is activated by PKA and 
suggests that the phosphorylation of this protein regulates short-term cholesterol 
synthesis in cell culture. 
 
Future Studies 
 
Since the last decade much information has been gained on this enigmatic 
protein, but the absolute mechanism of action has not been determined.  It is apparent 
that SPF is important for the short-term regulation of cholesterol synthesis in cell culture 
and this protein affects squalene monooxygenase in vitro.  This last section of the 
dissertation is dedicated to various prospective studies which would help unravel the 
mystery of this protein. 
We have mutated Ser289 to Ala, which in turn abolished the activity of SPF to be 
activated by protein kinase A in vitro and completely abolished the SPF-mediated 
stimulation of cholesterol synthesis in SPF-expressing cells.  Ser289 could also be 
mutated to Glu.  Because Glu carries a negative charge on its side chain carboxyl 
group, it resembles phosphorylated serine, and might substitute effectively for 
phosphoserine. Replacement of key amino acids with Glu has been shown to 
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constitutively activate other enzymatic systems.  This replacement would give us a 
definite insight to assess if Ser289 is indeed the key amino acid for the SPF-mediated 
cholesterol synthesis in cell culture and in vitro. 
I have also demonstrated the need for the Golgi apparatus in the SPF-mediated 
stimulation of cholesterol synthesis.  The next key step would be to create green 
fluorescent tagged protein (GFP) versions of SPF and assess the localization of this 
protein in cell culture using confocal microscopy or real-time imagery.  This strategy 
would help in visualizing the intracellular localization of this protein and give us a further 
perspective of this protein.  
 
In this study I demonstrate a unique finding: SPF stimulates the enzymes 
squalene monooxygenase and HMG-CoA reductase and thereby increase cholesterol 
synthesis in cell culture.  The activation of this protein by PKA phosphorylation suggests 
that cholesterol synthesis can be rapidly modulated in response to external stimuli by 
changes in cAMP levels.  To what extent this system operates in vivo to modulate 
cholesterol synthesis is an important area for future investigation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Copyright © Vishwesh Mokashi 2004 
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